This, in a nutshell, is how the ongoing Covid-19 immune escape pandemic will eventually end...
Aug 31, 2025
For those wondering how the current Covid-19 (C-19) immune escape pandemic will eventually play out:
In a natural coronavirus pandemic, protective herd immunity is enough to stop the virus. But the ongoing IMMUNE ESCAPE pandemic can only end when immune systems in highly C-19-vaccinated populations are collectively pushed to refocus and then eventually switched off, or silenced.
By triggering antibody-dependent enhancement of infection, Omicron promoted immune refocusing and thereby reduced viral virulence in highly Covid-19–vaccinated populations. HIVICRON (HI-ghly VI-rulent Omi-CRON descendant) , however, will shut down immune inflammation and collectively silence immune responses in these populations - a mechanism that will ultimately allow the virus to come back stronger and more virulent.
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.
Email: info@voiceforscienceandsolidarity.org
.svg){kind=small}
